Articles by Craig I. Coleman, PharmD
FDA approves Lorcaserin and Mirabegron extended-release tablets.
FDA has approved pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency resulting from cystic fibrosis or other conditions.
FDA approves avanafil and tafluprost
FDA approves Lucinactant and Peginesatide